Showing 1 - 10 of 18
The success of non-pharmaceutical interventions to contain pandemics often depends greatly upon voluntary compliance with government guidelines. What explains variation in voluntary compliance? Using mobile phone and survey data, we show that during the early phases of COVID- 19, voluntary...
Persistent link: https://www.econbiz.de/10013342571
We evaluate the net benefits of the Sarbanes-Oxley Act (SOX) for shareholders by studying the lobbying behavior of investors and corporate insiders to affect the final implemented rules under the Act. Investors lobbied overwhelmingly in favor of strict implementation of SOX, while corporate...
Persistent link: https://www.econbiz.de/10005720926
Persistent link: https://www.econbiz.de/10012240587
Persistent link: https://www.econbiz.de/10012230029
Persistent link: https://www.econbiz.de/10003840035
Persistent link: https://www.econbiz.de/10003843763
Persistent link: https://www.econbiz.de/10003459763
Persistent link: https://www.econbiz.de/10003434580
Persistent link: https://www.econbiz.de/10007719930
The success of non-pharmaceutical interventions to contain pandemics often depends greatly upon voluntary compliance with government guidelines. What explains variation in voluntary compliance? Using mobile phone and survey data, we show that during the early phases of COVID-19, voluntary social...
Persistent link: https://www.econbiz.de/10012481514